Michael Dooley - Concepedia

Author

Michael Dooley

Also Known As

Dooley, Michael, J. Simon Bell, M Dooley, M J Dooley, M. Dooley, M. J. DOOLEY, M. J. Dooley, M.J Dooley, M.J. Dooley, MICHAEL DOOLEY

297

Publications

5.1K

Citations

H-Index

194

Concepts

All Affiliations

Monash University Alfred Health The Alfred Hospital Peter MacCallum Cancer Centre The University of Melbourne

About

Michael Dooley is an author at Monash University specializing in medicine, patient safety, and health services research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	6	6	338
2	Business	4	4	82
3	Education	4	4	132
4	Management	2	2	39
5	Engineering	1	1	27

Michael Dooley

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals Michael Dooley, Karen Allen, Christopher J Doecke, British Journal of Clinical Pharmacology	2004	249
Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration Shalini Wickramaratne Senarath Yapa, Jian Li, Kashyap Patel, Antimicrobial Agents and Chemotherapy	2014	157
Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice Lesley Braun, Evelin Tiralongo, Ondine Spitzer, BMC Complementary and Alternative Medicine	2010	147
A Standard Weight Descriptor for Dose Adjustment in the Obese Patient Stephen B. Duffull, Michael Dooley, Bruce Green, Clinical Pharmacokinetics ObesityMetabolic SyndromeBariatric SurgeryDose AdjustmentBody Composition	2004	102
Reducing medication errors in hospital discharge summaries: a randomised controlled trial Erica Tong, Cristina Roman, Biswadev Mitra, The Medical Journal of Australia	2017	101
The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you? Phyllis Lau, Kay Stewart, Michael Dooley Supportive Care in Cancer Drug SafetyDrug HypersensitivityOncologyOncology PatientsAdverse Event	2003	88
Synthesis of Difficult Cyclic Peptides by Inclusion of a Novel Photolabile Auxiliary in a Ring Contraction Strategy Wim Meutermans, Simon W. Golding, Gregory T. Bourne, Journal of the American Chemical Society Conventional Cyclization ConditionsPeptide EngineeringMolecular BiologyOrganic ChemistryPeptide Science	1999	83
Attributable Hospital Cost and Antifungal Treatment of Invasive Fungal Diseases in High-Risk Hematology Patients: an Economic Modeling Approach Michelle Ananda‐Rajah, Allen Cheng, C. Orla Morrissey, Antimicrobial Agents and Chemotherapy	2011	83
The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre Jason A. Trubiano, Kelly A. Cairns, J Evans, BMC Infectious Diseases	2015	78
An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital Leon J. Worth, Michael Dooley, J.F. Seymour, British Journal of Cancer	2005	74

Page 1